Picture of Theratechnologies logo

TH Theratechnologies News Story

0.000.00%
ca flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapTurnaround

Brief: Theratechnologies Inc Confirms Bioequivalence Of New Tesamorelin Formulation

July 7 (Reuters) - Theratechnologies Inc  TH.TO :
    * THERATECHNOLOGIES INC - CONFIRMS BIOEQUIVALENCE OF NEW
TESAMORELIN FORMULATION
    * THERATECHNOLOGIES INC - SBLA EXPECTED TO BE FILED IN EARLY
2022

Source text for Eikon:  ID:nGNX6mpPZH 
Further company coverage:  TH.TO 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Theratechnologies

See all news